Latest Insider Transactions at Renaissancere Holdings LTD (RNR)
This section provides a real-time view of insider transactions for Renaissancere Holdings LTD (RNR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RENAISSANCERE HOLDINGS LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RENAISSANCERE HOLDINGS LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
7,050
+13.21%
|
-
|
|
Mar 01
2024
|
Shyam H Gidumal Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+22.53%
|
-
|
|
Mar 01
2024
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,263
-0.31%
|
$1,173,649
$223.35 P/Share
|
|
Mar 01
2024
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,678
+3.89%
|
-
|
|
Mar 01
2024
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+3.56%
|
-
|
|
Mar 01
2024
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-0.42%
|
$81,841
$223.35 P/Share
|
|
Mar 01
2024
|
David E Marra EVP,Chief Underwriting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,751
+6.44%
|
-
|
|
Mar 01
2024
|
Cynthia Trudell Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+12.3%
|
-
|
|
Mar 01
2024
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+3.41%
|
-
|
|
Mar 01
2024
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+9.04%
|
-
|
|
Mar 01
2024
|
Carol P Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+11.0%
|
-
|
|
Mar 01
2024
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,812
-0.56%
|
$404,076
$223.35 P/Share
|
|
Mar 01
2024
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,331
+6.65%
|
-
|
|
Mar 01
2024
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+5.7%
|
-
|
|
Mar 01
2024
|
Torsten Jeworrek Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+32.67%
|
-
|
|
Mar 01
2024
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,171
+3.36%
|
-
|
|
Mar 01
2024
|
Brian Gerald John Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
738
+2.85%
|
-
|
|
Feb 15
2024
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,789
-1.21%
|
$863,892
$228.61 P/Share
|
|
Feb 12
2024
|
Carol P Sanders Director |
SELL
Bona fide gift
|
Direct |
132
-2.46%
|
-
|
|
Feb 12
2024
|
Carol P Sanders Director |
SELL
Open market or private sale
|
Direct |
880
-7.11%
|
$199,760
$227.47 P/Share
|
|
Feb 07
2024
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.73%
|
$585,000
$234.57 P/Share
|
|
Jan 31
2024
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Open market or private sale
|
Direct |
750
-0.93%
|
$171,750
$229.0 P/Share
|
|
Jan 17
2024
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.23%
|
$209,000
$209.05 P/Share
|
|
Dec 01
2023
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+6.53%
|
-
|
|
Dec 01
2023
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+5.9%
|
-
|
|
Nov 21
2023
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.41%
|
$1,597,500
$213.83 P/Share
|
|
Nov 20
2023
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.21%
|
$207,000
$207.73 P/Share
|
|
Nov 07
2023
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,233
+4.2%
|
-
|
|
Nov 07
2023
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,233
+8.25%
|
-
|
|
Nov 07
2023
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,592
+10.79%
|
-
|
|
Nov 07
2023
|
Shannon Lowry Bender EVP, General Counsel & Secty |
BUY
Grant, award, or other acquisition
|
Direct |
7,233
+28.97%
|
-
|
|
Nov 07
2023
|
David E Marra EVP,Chief Underwriting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,233
+8.07%
|
-
|
|
Nov 01
2023
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
653
-0.86%
|
$147,578
$226.97 P/Share
|
|
Oct 25
2023
|
Henry Klehm Iii Director |
BUY
Open market or private purchase
|
Indirect |
13
+50.0%
|
$2,873
$221.08 P/Share
|
|
Sep 01
2023
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,769
-1.98%
|
$1,090,341
$189.64 P/Share
|
|
May 26
2023
|
Kevin O Donnell Pres & Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,020
+4.21%
|
$2,499,840
$192.0 P/Share
|
|
May 25
2023
|
Henry Klehm Iii Director |
SELL
Bona fide gift
|
Direct |
263
-1.29%
|
-
|
|
May 09
2023
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+7.19%
|
-
|
|
May 09
2023
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
475
+2.13%
|
-
|
|
May 09
2023
|
Torsten Jeworrek Director |
BUY
Grant, award, or other acquisition
|
Direct |
783
+50.0%
|
-
|
|
Mar 10
2023
|
Ross Curtis EVP,Chief Portfolio Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,255
-2.63%
|
-
|
|
Mar 10
2023
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,989
-2.07%
|
$1,161,866
$194.3 P/Share
|
|
Mar 10
2023
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,248
-3.75%
|
-
|
|
Mar 10
2023
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,151
-2.86%
|
$417,294
$194.3 P/Share
|
|
Mar 10
2023
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,038
-5.09%
|
-
|
|
Mar 10
2023
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,712
-3.49%
|
$526,128
$194.3 P/Share
|
|
Mar 10
2023
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,010
-4.91%
|
-
|
|
Mar 01
2023
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,602
+13.73%
|
-
|
|
Mar 01
2023
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,279
+4.58%
|
-
|
|
Mar 01
2023
|
Ian D Branagan EVP, Group Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,464
-0.74%
|
$534,688
$217.19 P/Share
|